Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a rang of key areas of expertise.
- Research Office
Business & Industry
Guiding Breakthrough Research at NUI Galway
We explore and facilitate commercial opportunities for the research community at NUI Galway, as well as facilitating industry partnership.
- Alumni, Friends & Supporters
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Professor Abhay Pandit
Introducing Abhay Pandit
Professor Abhay Pandit, a Professor in Biomedical Engineering, is the Director of the recently established 'Network of Excellence for Functional Biomaterials (NFB)'. Having joined the NCBES in 2002, he has played in immeasurable role in the development of biomaterials and tissue engineering research at NUI Galway. In recognition of the progress achieved thus far and the potential impact of research in the field of biomaterials, he received funding from Science Foundation Ireland (SFI) which has led to the establishment of NFB, a strategic research cluster (SRC) which is an extension of the world-class biomedical research currently being carried out at the NCBES.
Establishment of NFB
“The establishment of NFB is recognition of the critical mass of Biomaterials research at NUI, Galway. It is a good example of how convergent research streams can work together on a single platform,” said Prof. Pandit.
NFB comprises a staff of 47 researchers, lecturers, students and support staff. The cluster is a multi-institutional campus-industry partnership with institutions in Ireland, Canada, Switzerland and the USA, affiliated with the National Centre for Biomedical Engineering Science (NCBES) and the Regenerative Medicine Institute (REMEDI) incorporating the GMP grade vector and cell production facility. The unique feature of the research carried out at NFB is that it brings together a critical mass of expertise working on a single research platform to develop the next generation of biomaterials to provide solutions for current clinical needs.
Over 20 years experience in the field of designing biodegradable biomaterials
Prof Pandit has over 20 years experience in the field of designing biodegradable biomaterials. He pursued his postgraduate degree under the guidance of Prof Dale Feldman at the University of Alabama at Birmingham. The Feldman laboratory worked on the treatment of pressure ulcers using biomaterials for growth factor delivery, linking the laboratory to the clinic, allowing students to gain first hand experience of the clinical output of their research through interactions with clinical staff and patients. This direct clinical-patient interface was unique in the Feldman laboratory and cemented Prof Pandit's decision to continue researching biomaterials. “When I saw the opportunities that clinical translation made possible in the area of chronic wound healing, I was hooked. That my grandparents had suffered through debilitating forms of pressure ulcers made it clear that I should pursue a career in the field.”
Pandit's postgraduate work focussed on the synthesis and development of a fibrin scaffold for wound healing applications. The project involved the modification of a fibrin scaffold to deliver a therapeutic biomolecule. This work resulted in a clinical trial at the Burn Centre at the University of Alabama at Birmingham.
Subsequent research in the Wound Care R&D Group at The Kendall Company resulted in a patent and FDA approval for a commercial wound dressing. He also led the Biomaterials Research Group at Surgical Sealants, Inc. where he received IDE approval for a collagen-based vascular sealant and he was the principal investigator for a tissue-engineered heart valve project (NIST Funded US $2M) at St. Jude Medical, Inc.